Today on THCB Spotlight, Matthew sits down with Tendo’s CEO, Dan Goldsmith, and President, Jennifer Goldsmith. Tendo is in the patient engagement space, and Jennifer tells us about the vision behind the company – to become that trusted connection between patients, clinicians, and caregivers via software that creates a seamless and consumer-driven experience throughout that care journey. They talk to us about the plethora of point solutions for patient engagement, and how the platform approach that Tendo takes is meant to support a patient’s comprehensive needs without placing the full burden on the patients themselves.
Today, Matthew is back with another THCB Spotlight, this time with Shahram Seyedin-Noor, GP of Civilization Ventures. In this interview, Shahram tells us about how he got into venture and what he was doing before that, as well as his thinking around the focus of Civilization Ventures in catering to a new type of life science entrepreneur.
Today on THCB Spotlight, Matthew sits down with Marta Zanchi, who is the founder and Managing Partner at Nina Capital. Nina Capital is a micro venture capital firm in Barcelona, and in this interview, Matthew asks Marta about her decision to move from Silicon Valley to Barcelona and start this fund. Marta talks us through some of the investments they’ve made in the past couple of years so tune in to find out more.
Today on THCB Spotlights, Matthew Holt interviews CJ Wilson, the CEO of MyHealth.US. MyHealth.US provides wearable QR codes for instant access to emergency health information, as well as a digital platform to track your health data and house medical records. CJ shows us some of their offerings and explains how they’re working with unions and schools in NYC along with the company’s future plans for funding and growth.
Episode 22 of “The THCB Gang” was live-streamed on Thursday, August 20th! Watch it below.
Joining Matthew Holt (@boltyboy) today are some of our regulars: writer Kim Bellard (@kimbbellard), patient safety expert Michael Millenson (MLMillenson), MD & hospital system exec Rajesh Aggarwal (@docaggarwal), data privacy expert Deven McGraw (@healthprivacy), and Casey Quinlan (@MightyCasey). The conversation revolved around the responsibilities of the CDC & HHS, why the data hasn’t been shared properly around COVID19 transmission, and why payers & providers are cautiously innovating health care.
Today on THCB Spotlights, Matthew sits down with Paul Johnson, the CEO of Lemonaid. Lemonaid just closed a $33 million Series B led by Olive Tree Ventures, expanding their direct-to-consumer online services which provide primary care visits as well as pharmacy and medication delivery to your home and launching into more chronic areas of care, such as hypertension, high cholesterol, asthma and type 2 diabetes. Why did they wind up with an Israel-focused lead investor in Olive Tree as a San Francisco-based company? Where is Lemonaid in terms of growth and revenue? And how is Lemonaid differentiating itself against some of the other chronic care management and telehealth companies? Find out how the company aims to provide care for patients holistically and be the first point of contact for patients in seeking healthcare.
This is one of the more unusual videos I’ve done as a THCB Spotlight. I’ve been advising Allison Martin at UDoTest for a while. Meanwhile, I met Rahul Dubey when he was running innovation at AHIP. Then I saw his name all over Twitter and everywhere else because he had let a large number of protesters into his house as the police violently broke up a BLM protest earlier this month. What I didn’t know was how well they knew each other, but I got them together late last week and it made for a fascinating conversation about society, health care, and the future. —Matthew Holt
Stacie Ruth left mega conglomerate Philips when she ran into the chance to revolutionize drug delivery via nebulizers, and co-founded AireHealth. Along the way she realized that changing care for patients with respiratory conditions was actually a bigger problem and opportunity. In April she met Nirinjan Yee from Breath Research who had built an AI system that took lung sounds to predict exacerbations. Last week they merged their companies, and I spoke to them about what the new AireHealth will be doing. —Matthew Holt
Episode 11 of “The THCB Gang” was live-streamed on Thursday, May 27th and you can see it again below
Joining me were three regulars, patient safety expert Michael Millenson (MLMillenson), writer Kim Bellard (@kimbbellard), health futurist Ian Morrison (@seccurve), and two new guests: digital health investment banker Steven Wardell (@StevenWardell) and MD turned physician leadership coach Maggi Cary (@MargaretCaryMD)! The conversation was heavy on telemedicine and value based care, and their impact on the stock-market, the economy and the health care system–all in a week when we went over 100,000 deaths from COVID-19.
Today on THCB Spotlights, Matthew chats with a couple of the OGs from the original days of Health 2.0—Scott Shreeve, founder and CEO of Crossover Health, and Jay Parkinson, founder of Sherpaa, who were the first ones doing something different in terms of doctors figuring out this digital health stuff. The two of them ask the question, what would happen if you married the physical world with the online world and created a new care model that exceeds at both? While Scott was putting in onsite primary care clinics to employers like Apple and Facebook, he realized Crossover wasn’t reaching 70% of the people they were contracted with because many employees were geographically remote. Meanwhile, Jay was doing something similar with virtual primary care—which differs from traditional telehealth in that his model enables a true relationship between patient and provider—and the rest is history.